Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Enhertu (fam-trastuzumab deruxtecan-nxki) is a targeted antibody-drug conjugate used to treat specific types of HER2-expressing breast, lung, stomach, and other solid tumors
Enhertu (fam-trastuzumab deruxtecan-nxki) is a targeted antibody-drug conjugate used to treat specific types of HER2-expressing breast, lung, stomach, and other solid tumors